ArticleNature communications2022

Molecular and in vivo studies of a glutamate-class prolyl-endopeptidase for coeliac disease therapy.

Laura Del Amo-Maestro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.